Phase 2 study of cemiplimab in patients with metastatic cutaneous squamous cell carcinoma: primary analysis of fixed-dosing, long-term outcome of weight-based dosing
Danny Rischin, Michael R Migden, Annette M Lim, Chrysalyne D Schmults, Nikhil I Khushalani, Brett G M Hughes, Dirk Schadendorf, Lara A Dunn, Leonel Hernandez-Aya, Anne Lynn S Chang, Badri Modi, Axel Hauschild, Claas Ulrich, Thomas Eigentler, Brian Stein, Anna C Pavlick, Jessica L Geiger, Ralf Gutzmer, Murad Alam, Emmanuel Okoye, Melissa Mathias, Vladimir Jankovic, Elizabeth Stankevich, Jocelyn Booth, Siyu Li, Israel Lowy, Matthew G Fury, Alexander Guminski
Journal for ImmunoTherapy of Cancer Jun 2020, 8 (1) e000775; DOI: 10.1136/jitc-2020-000775